Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update

Go back to Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update
(NASDAQ: SION) Delayed: 7.30 +0.12 (1.67%)
Previous Close $7.18    52 Week High
Open $7.13    52 Week Low
Day High $7.56    P/E N/A 
Day Low $6.89    EPS
Volume 884,669